Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Reveal Pharmaceuticals

Reveal Pharmaceuticals

Vera Hoffman is the CEO and co-founder of Reveal Pharmaceuticals. She has directed startups and high growth enterprises from idea stage through global scale. Vera guided the design, development, and commercialization of over a dozen innovative technology-based products; led teams across six continents to identify, plan, and execute new business opportunities for one of the world&s;s largest companies; and developed the initial business plan for Acquia ($1B exit, 2019). Vera is Principal Investigator of Reveal&s;s multiple SBIR grants including Fast Track, Commercialization Readiness Program, Phase I, and Direct to Phase II SBIRs, which are funded by the National Cancer Institute, the National Institute for Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung and Blood Institute. She has degrees in Chemistry and Mathematics and an MBA from Harvard Business School. Co-Director, Institute for Innovation in Imaging, Massachusetts General Hospital Peter is a world leader in MRI contrast agent development and applications, with 20 years industrial and academic experience. He is co-inventor of RVP-001. Peter leads a molecular imaging lab at Massachusetts General Hospital (MGH) focused on contrast agents and molecular probes to image fibrosis and thrombosis, as well as alternatives to GBCAs. At MGH he invented two novel molecular tracers and he holds INDs for their ongoing clinical development. In industry Peter was part of the team that developed the FDA-approved blood pool agent Ablavar® (Gadofosveset), and was co-inventor of the thrombus-specific agent EP-2104R, the first molecular MR imaging probe to enter human clinical trials. Peter is a Fellow of the International Society for Magnetic Resonance in Medicine (ISMRM) and was awarded the 2019 Torsten Almén Award for Pioneering in Contrast Media Research. Srini is a neuroradiologist whose distinguished career in medicine encompasses clinical, research, and academic leadership. Prior to joining Reveal, Srini was Chief of Magnetic Resonance Imaging ...

Last updated on

About Reveal Pharmaceuticals

Founded

2016

Estimated Revenue

$1M-$10M

Employees

11-50

Category

Industry

Biotechnology

Location

City

Cambridge

State

Massachusetts

Country

United States

Tech Stack (9)

search

Analytics and Tracking

JavaScript Libraries and Functions

Email Hosting Providers

Web Servers